Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying sulindac to see how well it works compared to a
placebo in preventing lung cancer in current or former smokers with bronchial dysplasia.
Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming
back. The use of sulindac may prevent lung cancer from forming in patients with bronchial
dysplasia. It is not yet known whether sulindac is more effective than a placebo in
preventing lung cancer in patients with bronchial dysplasia.